Valuation: Bionik Laboratories Corp.

Market Cap 12 10.75 9.92 8.97 16.78 1.14T 17.05 118.3 47.2 598.05 45.03 44.08 1.89T P/E 2022
-0.21x
P/E 2023 -0.56x
Enterprise Value 19.85L 17.78L 16.4L 14.84L 27.76L 19Cr 28.2L 1.96Cr 78.07L 9.89Cr 74.49L 72.91L 31Cr EV / Sales 2022
0.17x
EV / Sales 2023 2.65x
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
1 day+9,900.00%
6 months+9,900.00%
Current year+9,900.00%
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
2.9
10 years 0
Extreme 0
222.02
Manager TitleAgeSince
Chief Executive Officer 46 14/07/2021
Director TitleAgeSince
Director/Board Member 35 18/03/2019
Director/Board Member 70 01/09/2017
Director/Board Member 46 13/10/2022
Date Insider Type Main position Quantity % Market Cap. Importance
13/06/23 Conversion

Chairman

1,86,112 1.4416%
13/06/23 Conversion

Director

31,02,878 24.0337%
09/06/23 Buy

Director

1,80,555 1.3985%
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-99.90% 1.26T
+0.71%+4.82%+27.02%+64.39% 26TCr
+1.24%+3.15%+10.73%+26.13% 16TCr
+1.03%+1.11%-16.52%+73.28% 15TCr
+0.61%-7.22%-57.44%-13.79% 6.15TCr
+2.90%+4.83%+14.21%+53.04% 5.29TCr
+0.70%+2.71%-13.09%-6.48% 5.28TCr
-2.35%-3.79%+8.26%+63.75% 5.15TCr
-0.18%+4.18%+26.50%+76.27% 5.12TCr
+0.67%+5.37%+39.77%+96.14% 4.69TCr
Average +990.53%+1.52%+3.94%+33.28% 8.96TCr
Weighted average by Cap. +0.76%+2.42%+7.18%+50.97%

Financials

2022 2023
Net sales 12.74L 11.41L 10.53L 10L 17.81L 12Cr 18.1L 1.26Cr 50.1L 6.35Cr 47.8L 46.78L 20Cr 18.05L 16.17L 14.92L 13.5L 25.24L 17Cr 25.65L 1.78Cr 71L 9Cr 67.75L 66.31L 28Cr
Net income -1.04Cr -93.22L -86.01L -77.83L -1.46Cr -99Cr -1.48Cr -10Cr -4.09Cr -52Cr -3.91Cr -3.82Cr -164.29Cr -49.46L -44.3L -40.87L -36.99L -69.16L -47Cr -70.28L -4.88Cr -1.95Cr -25Cr -1.86Cr -1.82Cr -78Cr
Net Debt -19.91L -17.84L -16.46L -14.89L -27.85L -19Cr -28.3L -1.96Cr -78.32L -9.92Cr -74.73L -73.14L -31Cr 19.85L 17.78L 16.4L 14.84L 27.76L 19Cr 28.2L 1.96Cr 78.07L 9.89Cr 74.49L 72.91L 31Cr
Logo Bionik Laboratories Corp.
Bionik Laboratories Corp. is a healthcare company focused on supplying solutions to those with movement impairments. Its product portfolio includes three InMotion Robots for rehabilitation following stroke and other neurological conditions and four products in varying stages of development. The InMotion robots offer patient-adaptive therapy, intended to restore upper-extremity motor control for a range of neurological conditions and recovery stages, including early recovery from acute stroke. InMotion Robots also provide objective evaluation assessments intended to measure and report the patient’s level of motor impairment and progress during therapy. Its solutions include InMotion Therapy, InMotion ARM, InMotion ARM/HAND, InMotion EVAL, InMotion Connect, InMotion for Physical Therapy, and InMotion for Occupational Therapy. InMotion Robotics provides the occupational therapist with a range of useful protocols designed to reduce many types of upper extremity neurological impairments.
Employees
-
  1. Stock Market
  2. Stocks
  3. BNKL Stock